Georgios L.
- Country
- Greece
- Department
- Clinic of Medical Oncology
Research Overview
- Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Phase 1b/2 Umbrella Study of MK-1084 and Combination Therapy in Patients With Previously Treated Advanced or Metastatic KRAS G12C-Mutated Nonsquamous NSCLC
- Pumitamig Versus Durvalumab After Concurrent Chemoradiation in Unresectable Stage III Non-Small Cell Lung Cancer Without Progression
Data & Insights
Has run more than one trial at 61 of 232 partner sites.
Specializations
Lung Cancer Research
Specializes in the treatment of stage III unresectable non-small cell lung cancer (NSCLC), with particular focus on combination immunotherapy approaches following concurrent chemoradiation.
- Advanced NSCLC Management
- Immunotherapy Combinations
- PD-L1 Expression Analysis
Explores innovative therapeutic strategies for patients with locally advanced disease.
Melanoma Studies
Investigates treatment administration methods for melanoma patients, focusing on comparing intravenous and subcutaneous immunotherapy delivery systems.
- Treatment Administration Routes
- Patient Preference Assessment
- Immunotherapy Optimization
Evaluates patient-centered approaches in melanoma treatment delivery.
Head and Neck Cancer
Focuses on treating recurrent or metastatic head and neck squamous cell carcinoma, investigating novel combination therapies with targeted agents and immunotherapy.
- Combination Treatment Strategies
- Advanced Disease Management
- Targeted Therapy Applications
Explores innovative therapeutic combinations for improved patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.